We are live on ! Find out more
Tudor Investment Corp

Tudor Investment Corp Portfolio holdings

AUM $53.9B
1-Year Est. Return 29.12%
This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+29.12%
3 Year Est. Return
+77.1%
5 Year Est. Return
+83.79%
10 Year Est. Return
+526.01%
AUM
$19.5B
AUM Growth
+$3.8B
Cap. Flow
+$4.18B
Cap. Flow %
21.4%
Top 10 Hldgs %
34.26%
Holding
2,929
New
786
Increased
755
Reduced
667
Closed
671

Sector Composition

Rank Sector Weight
1 Technology 8.69%
2 Industrials 5.51%
3 Financials 5.39%
4 Consumer Discretionary 5.21%
5 Healthcare 5.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRCL
2901
DELISTED
Stericycle Inc
SRCL
-25,962
Closed -$1.37M
AAN
2902
DELISTED
The Aaron's Company Inc
AAN
-67,957
Closed -$510K
PWSC
2903
DELISTED
PowerSchool Holdings, Inc.
PWSC
-27,859
Closed -$593K
CALT
2904
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
-65
Closed -$1.37K
BIG
2905
DELISTED
Big Lots, Inc.
BIG
-102,038
Closed -$442K
LSXMK
2906
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
-162,851
Closed -$4.84M
TWOU
2907
DELISTED
2U Inc
TWOU
-4,573
Closed -$53.5K
MOR
2908
DELISTED
MorphoSys AG American Depositary Shares
MOR
-343,310
Closed -$6.23M
SBOW
2909
DELISTED
SilverBow Resources, Inc.
SBOW
-8,564
Closed -$292K
WRK
2910
DELISTED
WestRock Company
WRK
-72,934
Closed -$3.61M
AIRC
2911
DELISTED
Apartment Income REIT Corp.
AIRC
-328,702
Closed -$10.7M
HRT
2912
DELISTED
HireRight Holdings Corporation
HRT
-141,809
Closed -$2.02M
DCPH
2913
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
-39,525
Closed -$622K
FUSN
2914
CALL
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
-52,500
Closed -$1.12M
FUSN
2915
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
-32,919
Closed -$702K
LICY
2916
DELISTED
Li-Cycle Holdings Corp.
LICY
-52,536
Closed -$433K
SWAV
2917
CALL
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
-700
Closed -$228K
CLVT.PRA
2918
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
-15,000
Closed -$446K
ERF
2919
DELISTED
Enerplus Corporation
ERF
-162,992
Closed -$3.2M
ALPN
2920
DELISTED
Alpine Immune Sciences Inc
ALPN
-50,729
Closed -$2.01M
MIR.WS
2921
CALL
DELISTED
Mirion Technologies, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MIR.WS
-24,999
Closed -$56K
TAST
2922
DELISTED
Carrols Restaurant Group, Inc.
TAST
-49,665
Closed -$472K
PXD
2923
DELISTED
Pioneer Natural Resource Co.
PXD
-1,056,396
Closed -$277M
SAVAW
2924
CALL
DELISTED
Cassava Sciences, Inc. Warrant
SAVAW
-10,651
Closed -$27.8K
TCN
2925
DELISTED
Tricon Residential Inc.
TCN
-5,001,114
Closed -$55.8M

Similar funds

Tudor Investment Corp's Q2 2024 Portfolio in Review

As of Q2 2024, Tudor Investment Corp held 2,929 positions worth $19.5B, up 24% from $15.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tudor Investment Corp deployed $4.18B of net new capital in Q2 2024, opening 786 new positions and adding to 755 existing holdings. Its largest new stake was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, down from 8.9% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Micron Technology, an estimated $59M trimmed.

  • Tudor Investment Corp's largest Q2 2024 buy was Bristol-Myers Squibb: 2,000,813 shares worth $83.1M.
  • Tudor Investment Corp added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $122M increase.
  • Tudor Investment Corp's biggest Q2 2024 reduction was Micron Technology, cutting an estimated $59M.
  • Tudor Investment Corp fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $277M.
  • Tudor Investment Corp's ten largest holdings make up 34% of its $19.5B portfolio in Q2 2024.
  • Tudor Investment Corp opened 786 new positions and closed 671 in Q2 2024.
  • Tudor Investment Corp's portfolio value rose 24% quarter-over-quarter to $19.5B.

Based on Tudor Investment Corp's 13F filing for Q2 2024, filed 14 Aug 2024.